Drapkin Kimberlee C

CIK 00013408816 companiesSOLANA BEACH, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001340881

Recent Transactions

50 trades

Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2026-06-15+22,100→ 22,100 total
Award
Climb Bio, Inc.$CLYM
Stock Option (Right to Buy)
2026-06-05+40,000→ 40,000 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-06-03+35,500→ 48,300 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2026-06-03+53,250→ 53,250 total
Disposition to Issuer
KINETA, INC./DE
Common Stock
2025-06-30−13,794→ 0 total
Disposition to Issuer
KINETA, INC./DE
Stock Option (Right to Buy)
2025-06-30−20,000→ 0 total
Award
KINETA, INC./DE
Common Stock
2025-06-25+6,000→ 13,794 total
Exercise/Conversion
KINETA, INC./DE
Common Stock
2025-06-23$0.61/sh+12,500→ 12,500 total
Tax Payment
KINETA, INC./DE
Common Stock
2025-06-23$0.26/sh−4,706→ 7,794 total
Exercise/Conversion
KINETA, INC./DE
Stock Option (Right to Buy)
2025-06-23−12,500→ 0 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2025-06-11+13,500→ 13,500 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-06-04+12,800→ 12,800 total
Award
Climb Bio, Inc.$CLYM
Stock Option (Right to Buy)
2025-06-04+40,000→ 40,000 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2025-06-04+19,500→ 19,500 total
Award
Climb Bio, Inc.$CLYM
Stock Option (Right to Buy)
2025-03-28+80,000→ 80,000 total
Award
KINETA, INC./DE
Stock Option (Right to Buy)
2024-09-04+12,500→ 12,500 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2024-06-10+25,000→ 25,000 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2024-03-21+27,000→ 27,000 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2023-07-28+40,000→ 40,000 total
Award
KINETA, INC./DE
Stock Option (Right to Buy)
2023-07-01+20,000→ 20,000 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2023-06-06+25,000→ 25,000 total
Disposition from Tender
Jounce Therapeutics, Inc.
Common Stock
2023-05-03−25,751→ 40,267 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−55,000→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−206,005→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−8,130→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−77,235→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−97,500→ 0 total
Disposition from Tender
Jounce Therapeutics, Inc.
Common Stock
2023-05-03−40,267→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−44,500→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−53,400→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−44,500→ 0 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2023-01-10$1.12/sh−7,781→ 66,018 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2023-01-09$1.10/sh−6,315→ 73,799 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (right to buy)
2022-06-15+25,000→ 25,000 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option Grant (right to buy)
2022-04-01+50,000→ 50,000 total
Award
Jounce Therapeutics, Inc.
Common Stock
2022-02-01+27,500→ 80,114 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-01+55,000→ 55,000 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2022-01-10$6.65/sh−8,222→ 52,614 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2022-01-07$7.30/sh−4,595→ 60,836 total
Award
KINETA, INC./DE
Stock Option (Right to Buy)
2021-06-02+14,800→ 14,800 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2021-02-01+44,500→ 44,500 total
Award
Jounce Therapeutics, Inc.
Common Stock
2021-02-01+22,250→ 65,431 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2021-01-21$12.00/sh−3,799→ 43,181 total
Exercise/Conversion
Jounce Therapeutics, Inc.
Common Stock
2021-01-21$2.36/sh+3,799→ 46,980 total
Exercise/Conversion
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-21−3,799→ 206,005 total
Exercise/Conversion
Jounce Therapeutics, Inc.
Common Stock
2021-01-20$0.48/sh+3,016→ 58,897 total
Exercise/Conversion
Jounce Therapeutics, Inc.
Common Stock
2021-01-20$0.74/sh+6,775→ 65,672 total
Exercise/Conversion
Jounce Therapeutics, Inc.
Common Stock
2021-01-20$2.36/sh+3,710→ 69,382 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2021-01-20$10.03/sh−10,000→ 43,181 total
Exercise/Conversion
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-20−3,016→ 0 total

Drapkin Kimberlee C

Recent Transactions

Companies

Recent Filings

Address